Table I.

Patient characteristics, n = 138. Data reported as median (interquartile range (IQR)) or frequency (percent (%)).

Female sex, n (%)	48 (35%)
Age at metastasectomy, y (IQR)	64 (56, 70)
Any clear cell histology at nephrectomy, n (%)	108 (78%)
Only clear cell histology at nephrectomy, n (%)	97 (70%)
Sarcomatoid histology at nephrectomy, n (%)	8 (5.8%)
Synchronous disease, n (%)	30 (22%)
Site of metastasectomy, n (%)
Adrenal	27 (20%)
Liver	12 (8.7%)
Lung	78 (57%)
Pancreas	15 (11%)
Thyroid	6 (4.3%)
Multiple tumors removed at metastasectomy, n (%)	51 (37%)
Karnofsky Performance Score (n = 89), n (%)
≤75	3 (3.3%)
80	17 (19%)
85	2 (2.2%)
90	58 (65%)
100	9 (10%)
Confirmed systemic therapy, n (%)	74 (54%)